Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
Phase 1
Active, not recruiting
- Conditions
- Keratoconjunctivitis SiccaDry EyeOcular Inflammation
- Interventions
- Device: punctum plug insertionDrug: Eye Drops, Lubricant
- First Posted Date
- 2022-11-16
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Eximore Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT05618730
- Locations
- 🇲🇽
Asociación para Evitar la Ceguera en México (APEC), Mexico City, Coyoacán, Mexico
News
No news found